Establishes a working group to create a roadmap for polycystic kidney disease research and innovation.
The PKD Cures Act mandates the Director of the National Institutes of Health to establish a working group focused on polycystic kidney disease (PKD). This group will develop a comprehensive roadmap for PKD research and innovation, including basic research, translational research, and clinical research. The working group will identify research gaps, recommend strategies for public-private collaboration, and propose timelines for achieving key milestones. The Director must prioritize research proposals with potential to advance PKD understanding and treatment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.